| 名稱 | EGFR H773_V774insAH/BaF3 |
| 型號(hào) | CBP73220 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | EGFR H773_V774insAH/BaF3,母細(xì)胞：BaF3，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 耳聾基因檢測(cè)標(biāo)準(zhǔn)品
- 老靶點(diǎn)迭代突破創(chuàng)新：Her2靶點(diǎn)細(xì)胞模型
- 潛力十足的T細(xì)胞療法，我們用得起嗎？
- GLP-1R、GCGR、GIPR多靶點(diǎn)激動(dòng)劑與代謝疾病
- ATCC細(xì)胞的培養(yǎng)方法
- 近期淋巴癌重磅級(jí)研究一覽
- 4-1BB（CD137）靶點(diǎn)藥物篩選模型
- 新型冠狀病毒：用于診斷的假病毒標(biāo)準(zhǔn)品和用于藥物研發(fā)的假病毒模型
- 腫瘤細(xì)胞調(diào)控關(guān)鍵因子和機(jī)制的研究講解
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73220EGFR H773_V774insAH/BaF3
- 詳細(xì)內(nèi)容
| CBP73220 | |
| I. Introduction | |
Cell Line Name： | EGFR H773_V774insAH/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
EGFR H773_V774insAH results in the insertion of two amino acids within the drug-binding pocket in the protein kinase domain of the Egfr protein between amino acids 773 and 774 (UniProt.org, PMID: 23371856). H773_V774insAH has not been biochemically characterized, but is predicted to result in a gain of function based on the effect of other Egfr exon 20 insertion mutations (PMID: 24353160). | |
| III. Representative Data | |
1. WB of EGFR H773_V774insAH/BaF3
| |
會(huì)員_a.png)